ENALLYLPROPYMAL

Details

Stereochemistry	RACEMIC
Molecular Formula	C11H16N2O3
Molecular Weight	224.2563
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O

InChI

InChIKey=AXJXURWWUFZZKN-UHFFFAOYSA-N

InChI=1S/C11H16N2O3/c1-5-6-11(7(2)3)8(14)12-10(16)13(4)9(11)15/h5,7H,1,6H2,2-4H3,(H,12,14,16)

HIDE SMILES / InChI

Molecular Formula	C11H16N2O3
Molecular Weight	224.2563
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Approval Year

PubMed

Title	Date	PubMed
Identification of the UDP-glucuronosyltransferase responsible for bucolome N-glucuronide formation in rats.	2010-11	21155392
Hydrogen-bond motifs in N-monosubstituted derivatives of barbituric acid: 5-allyl-5-isopropyl-1-methylbarbituric acid (enallylpropymal) and 1,5-di(but-2-enyl)-5-ethylbarbituric acid.	2010-01	20048427
Risks and benefits of combined use of bucolome and warfarin in anticoagulation therapy.	2010	21173515
Interferon-alpha is a predisposing risk factor for carbamazepine-induced hyponatremia: A case of syndrome of inappropriate antidiuresis caused by interferon-alpha therapy.	2008-11-30	20428402
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.	2008-07	18390890
The effect of bucolome, a CYP2C9 inhibitor, on the pharmacokinetics of losartan.	2008	18445991
[Intraluminal ureteral hematoma complicating anticoagulant therapy].	2005-07	16083035
Usefulness of coadministration of bucolome in warfarin therapy: pharmacokinetic and pharmacodynamic analysis using outpatient prescriptions.	2005-04-11	15778043
Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.	2005-04	15640375
Metabolism of bucolome in rats. Stability and biliary excretion of bucolome N-glucuronide.	2001-08-05	11499619
The stereoselective effects of bucolome on the pharmacokinetics and pharmacodynamics of racemic warfarin.	2001-04	11304904

Patents

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:42:30 GMT 2025` Edited by `admin` on `Mon Mar 31 22:42:30 GMT 2025`
Record UNII	17BT2X209M
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

NSC-25571

Preferred Name

English

ENALLYLPROPYMAL

Common Name

English

2,4,6(1H,3H,5H)-PYRIMIDINETRIONE, 1-METHYL-5-(1-METHYLETHYL)-5-(2-PROPEN-1-YL)-

Systematic Name

English

N-METHYL-5-ALLYL-5-ISOPROPYLBARBITURIC ACID

Systematic Name

English

5-ALLYL-5-ISOPROPYL-1-METHYLBARBITURIC ACID

Systematic Name

English

ENALLYLPROPYMAL [MI]

Common Name

English

NARCONUMAL

Common Name

English

Code System Code Type Description

DRUG CENTRAL

3448